In the Operating Room: From Suture & Staples to Tissue Fusion скачать в хорошем качестве

In the Operating Room: From Suture & Staples to Tissue Fusion

First Major New Surgical Closure Technology in 40 Years Advances in operating and emergency room technologies occur at a blistering pace. Novel procedures and equipment become routine rapidly as the range of what is possible expands continuously. But surgical closure methods have not seen meaningful innovation for almost three (3) decades. While the use of traditional sutures & staples is well understood and adequate for many applications, they have serious limitations and drawbacks in others, such as in gastrointestinal, lung, liver, and pancreas surgeries, among others. BioFuse offers the promise of continuous surgical closure using its distinctive multi-tissue fusion (MTF) platform technology and also has extensive animal and ex-US human data to support the safety & efficacy of its game-changing approach. Join us as Dr. David Battleman, President & CEO of Biofuse Medical provides an overview of this unique market opportunity and how Biofuse has developed technology to take advantage of it. Don't miss an opportunity to learn about a compelling value investment in cutting-edge, highly disruptive, and de-risk breakthrough surgical technology with the potential to reshape the future of the global surgical closure market.